CN105250723A - 一种治疗糖尿病的药物 - Google Patents
一种治疗糖尿病的药物 Download PDFInfo
- Publication number
- CN105250723A CN105250723A CN201510690480.3A CN201510690480A CN105250723A CN 105250723 A CN105250723 A CN 105250723A CN 201510690480 A CN201510690480 A CN 201510690480A CN 105250723 A CN105250723 A CN 105250723A
- Authority
- CN
- China
- Prior art keywords
- polygonatum
- medicine
- diabetes
- ginseng
- corydalis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 28
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 229940079593 drug Drugs 0.000 title description 5
- 241000756042 Polygonatum Species 0.000 claims abstract description 20
- 240000004371 Panax ginseng Species 0.000 claims abstract description 16
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 16
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 16
- 235000008434 ginseng Nutrition 0.000 claims abstract description 16
- 241000092665 Atractylodes macrocephala Species 0.000 claims abstract description 11
- 244000248557 Ophiopogon japonicus Species 0.000 claims abstract description 11
- 241000202726 Bupleurum Species 0.000 claims abstract description 10
- 241000005787 Cistanche Species 0.000 claims abstract description 10
- 240000004307 Citrus medica Species 0.000 claims abstract description 10
- 241000218176 Corydalis Species 0.000 claims abstract description 10
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 10
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 10
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 10
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 10
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 10
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 10
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 10
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 10
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 10
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 10
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 10
- 241001523681 Dendrobium Species 0.000 claims abstract description 10
- 241001289529 Fallopia multiflora Species 0.000 claims abstract description 10
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 10
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 10
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 10
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 10
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 10
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 10
- 241000234435 Lilium Species 0.000 claims abstract description 10
- 244000179970 Monarda didyma Species 0.000 claims abstract description 10
- 235000010672 Monarda didyma Nutrition 0.000 claims abstract description 10
- 241000237502 Ostreidae Species 0.000 claims abstract description 10
- 241000913745 Spatholobus Species 0.000 claims abstract description 10
- 229940010454 licorice Drugs 0.000 claims abstract description 10
- 235000020636 oyster Nutrition 0.000 claims abstract description 10
- 241000675108 Citrus tangerina Species 0.000 claims abstract description 9
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 8
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 8
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 8
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 8
- 241000405911 Rehmannia glutinosa Species 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 241001633583 Adenophora Species 0.000 claims abstract description 5
- 240000002624 Mespilus germanica Species 0.000 claims abstract description 3
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 3
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 3
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 3
- 240000000249 Morus alba Species 0.000 claims description 11
- 235000008708 Morus alba Nutrition 0.000 claims description 11
- 240000002045 Guettarda speciosa Species 0.000 claims description 9
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 9
- 244000241838 Lycium barbarum Species 0.000 claims description 7
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 7
- 241000218989 Trichosanthes Species 0.000 claims description 7
- 240000002853 Nelumbo nucifera Species 0.000 claims description 5
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 5
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 5
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 4
- 241000405414 Rehmannia Species 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 241000244365 Ligusticum sinense Species 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 241000270666 Testudines Species 0.000 claims description 2
- 240000006023 Trichosanthes kirilowii Species 0.000 claims description 2
- 108010021119 Trichosanthin Proteins 0.000 claims description 2
- 240000008866 Ziziphus nummularia Species 0.000 claims 2
- 241000258963 Diplopoda Species 0.000 claims 1
- 241001061264 Astragalus Species 0.000 abstract description 8
- 235000006533 astragalus Nutrition 0.000 abstract description 8
- 210000004233 talus Anatomy 0.000 abstract description 8
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 6
- 244000126002 Ziziphus vulgaris Species 0.000 abstract description 6
- 244000236658 Paeonia lactiflora Species 0.000 abstract description 2
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 44
- 239000008280 blood Substances 0.000 description 44
- 210000004072 lung Anatomy 0.000 description 39
- 210000000952 spleen Anatomy 0.000 description 33
- 210000004185 liver Anatomy 0.000 description 31
- 210000002784 stomach Anatomy 0.000 description 29
- 210000003734 kidney Anatomy 0.000 description 27
- 235000009508 confectionery Nutrition 0.000 description 23
- 206010011224 Cough Diseases 0.000 description 20
- 230000007812 deficiency Effects 0.000 description 19
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 17
- 239000008103 glucose Substances 0.000 description 17
- 230000035922 thirst Effects 0.000 description 16
- 210000001124 body fluid Anatomy 0.000 description 14
- 239000010839 body fluid Substances 0.000 description 14
- 208000002193 Pain Diseases 0.000 description 13
- 206010016256 fatigue Diseases 0.000 description 13
- 206010062717 Increased upper airway secretion Diseases 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 11
- 208000026435 phlegm Diseases 0.000 description 11
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 206010033557 Palpitations Diseases 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 9
- 206010036067 polydipsia Diseases 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 238000010791 quenching Methods 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 8
- 208000031971 Yin Deficiency Diseases 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 230000000171 quenching effect Effects 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 206010022437 insomnia Diseases 0.000 description 7
- 230000000291 postprandial effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000008454 Hyperhidrosis Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 208000017574 dry cough Diseases 0.000 description 6
- 210000003127 knee Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 210000005036 nerve Anatomy 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 206010020710 Hyperphagia Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 201000001421 hyperglycemia Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 208000022530 polyphagia Diseases 0.000 description 5
- 230000035900 sweating Effects 0.000 description 5
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 208000037093 Menstruation Disturbances Diseases 0.000 description 4
- 206010027339 Menstruation irregular Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 210000001508 eye Anatomy 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000010025 steaming Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010059013 Nocturnal emission Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 239000003472 antidiabetic agent Substances 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 235000004879 dioscorea Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 239000008141 laxative Substances 0.000 description 3
- 230000002475 laxative effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- 208000016261 weight loss Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 229940100389 Sulfonylurea Drugs 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000009108 consolidation therapy Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 108091005995 glycated hemoglobin Proteins 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241001633680 Polygonatum odoratum Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 241001247821 Ziziphus Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000010227 chenpi Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000006443 lactic acidosis Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 208000004235 neutropenia Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000007410 oral glucose tolerance test Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000008517 radix Trichosanthis Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000009396 suanzaoren Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种治疗糖尿病的药物。它由下述原料药制成:人参、黄芪、何首乌、黄精、山药、陈皮、白术、肉苁蓉、女贞子、紫河车、枸杞子、柴胡、佛手、香橼、白芍、石斛、山楂、沙棘、北沙参、鳖甲、牡蛎、玉竹、天花粉、麦冬、百合、莲子、酸枣仁、当归、川芎、延胡索、鸡血藤、桑叶、生地黄和甘草。本发明以纯中药组方,可以有效治疗糖尿病。经临床验证,其治疗有效率为100%。
Description
技术领域
本发明涉及一种治疗糖尿病的药物,属于中药技术领域。
背景技术
糖尿病是一组以高血糖为特征的代谢性疾病。高血糖则是由于胰岛素分泌缺陷或其生物作用受损,或两者兼有引起。其典型特征为“三多一少”症状,即多饮、多尿、多食及体重减轻,且伴有疲乏无力。糖尿病的主要诱因包括肥胖、体力活动过少和应激。应激包括紧张、劳累、精神刺激、外伤、手术、分娩、其他重大疾病,以及使用升高血糖的激素等等。由于上述诱因,患者的胰岛素分泌能力及身体对胰岛素的敏感性逐渐降低,血糖升高,导致糖尿病。中国是糖尿病大国,在糖尿病人口绝对数上一直以来都是全球之冠,2010年中国成人糖尿病患病率已达到11.6%,因此必须引起高度重视。糖尿病本身不一定造成危害,但长期血糖增高,大血管、微血管受损并危及心、脑、肾、周围神经、眼睛、足等。据世界卫生组织统计,糖尿病并发症高达100多种,是目前已知并发症最多的一种疾病。其中最常见的并发症为糖尿病肾病、糖尿病眼部并发症和糖尿病足。
糖尿病分为1型和2型,其中2型糖尿病占90%以上。目前临床治疗2型糖尿病的药物除胰岛素外,多是化学药物如磺脲类、双胍类等。长期注射胰岛素容易引发低血糖、体重增加、水肿等;磺脲类降糖药物较易引发低血糖、粒细胞减少及心血管疾病等不良反应;双胍类降糖药大剂量可引起消化道反应,在肺、肝、肾有病变的患者易致乳酸性酸中毒。因此,上述药物都存在一定的安全隐患。
发明内容
本发明克服了上述现有技术的不足,提供了一种治疗糖尿病的药物。该药物以纯中药制剂组方,可以有效治疗糖尿病。
本发明的技术方案是:一种治疗糖尿病的药物,其特征是,由下述重量份的原料药制成:人参18-22、黄芪25-35、何首乌22-28、黄精18-22、山药10-15、陈皮12-18、白术8-12、肉苁蓉18-22、女贞子12-18、紫河车5-10、枸杞子5-10、柴胡12-18、佛手8-12、香橼8-12、白芍5-10、石斛3-8、山楂10-15、沙棘8-12、北沙参5-10、鳖甲12-18、牡蛎5-10、玉竹5-10、天花粉5-10、麦冬5-10、百合5-10、莲子8-12、酸枣仁10-15、当归12-18、川芎8-12、延胡索5-10、鸡血藤3-8、桑叶3-8、生地黄8-12和甘草3-8。
优选配比:人参20、黄芪30、何首乌25、黄精20、山药12、陈皮15、白术10、肉苁蓉20、女贞子15、紫河车8、枸杞子8、柴胡15、佛手10、香橼10、白芍8、石斛5、山楂12、沙棘10、北沙参8、鳖甲15、牡蛎8、玉竹8、天花粉8、麦冬8、百合8、莲子10、酸枣仁12、当归15、川芎10、延胡索8、鸡血藤5、桑叶5、生地黄10和甘草5。
配制及服用方法:水煎煮,每日1剂,分两次早晚服用。1个月为1个疗程。一般服用2-5个疗程。
上述原料药还可以进一步加入制备不同剂型时所需的各种常规辅料,如赋形剂、崩解剂、矫味剂、粘合剂等以常规的中药制剂方法制备成任何一种常用口服制剂,如制成颗粒剂、丸剂、胶囊剂、片剂等。
各原料药理作用:
人参:甘、微苦,平。归脾、肺、心经。功能与主治:大补元气,复脉固脱,补脾益肺,生津,安神。用于体虚欲脱,肢冷脉微,脾虚食少,肺虚喘咳,津伤口渴,内热消渴,久病虚羸,惊悸失眠,阳痿宫冷,心力衰竭,心原性休克。
黄芪:甘,温。归肺、脾经。补气升阳,益卫固表、托毒生肌、利水退肿。主治脾胃虚弱,食少倦怠,气虚血脱,表虚自汗、盗汗。
何首乌:味甘,温,无毒。入脾、肺、肾三经。功能与主治:养血滋阴,润肠通便,祛风,解毒。主血虚头昏目眩,心悸,失眠,肝肾阴虚之腰膝酸软,须发早白,耳鸣,遗精,肠燥便秘,久疟体虚,风疹瘙痒,疮痈,瘰疬,痔疮。
黄精:甘,平。归脾、肺、肾经。功能与主治:补气养阴,健脾,润肺,益肾。用于脾胃气虚,体倦乏力,胃阴不足,口干食少,肺虚燥咳,劳嗽咳血,精血不足,腰膝酸软,须发早白,内热消渴。
山药:甘,平。归脾、肺、肾经。补脾养胃,生津益肺,补肾涩精。用于脾虚食少,久泻不止,肺虚喘咳,肾虚遗精,带下,尿频,虚热消渴。
陈皮:苦、辛,温。归肺、脾经。功能与主治:理气健脾,燥湿化痰。用于脘腹胀满,食少吐泻,咳嗽痰多。
白术:苦、甘,温。归脾、胃经。健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。
肉苁蓉:甘、咸,温。归肾、大肠经。补肾阳,益精血,润肠通便。治阳痿,不孕,腰膝酸软,筋骨无力;肠燥便秘。
女贞子:甘、苦,凉。归肝、肾经。滋补肝肾,明目乌发。用于肝肾阴虚,眩晕耳鸣,腰膝酸软,须发早白,目暗不明,内热消渴,骨蒸潮热。
紫河车:性味甘、咸、温,入肺、心、肾经,有补肾益精,益气养血之功。
枸杞子:味甘,性平。归肝、肾、肺经。功能与主治:养肝、滋肾、润肺。用于肝肾亏虚,头晕目眩,目视不清,腰膝酸软,阳痿遗精,虚劳咳嗽,消渴引饮。
柴胡:辛、苦,微寒。归肝、胆、肺经。功能与主治:疏散退热,疏肝解郁,升举阳气。用于感冒发热,寒热往来,胸胁胀痛,月经不调,子宫脱垂,脱肛。
佛手:辛、苦、酸,温。归肝、脾、胃、肺经。功能与主治:疏肝理气,和胃止痛,燥湿化痰。用于肝胃气滞,胸胁胀痛,胃脘痞满,食少呕吐,咳嗽痰多。
香橼:辛、苦、酸,温。归肝、脾、肺经。功能与主治:舒肝理气,宽中,化痰。用于肝胃气滞,胸胁胀痛,脘腹痞满,呕吐噫气,痰多咳嗽。
白芍:苦、酸,微寒。归肝、脾经。功能与主治:养血调经,敛阴止汗,柔肝止痛,平抑肝阳。用于血虚萎黄,月经不调,自汗,盗汗,肋痛,腹痛,四肢挛痛,头痛眩晕。
石斛:甘淡,微咸,寒。入胃、肺,肾经。生津益胃,清热养阴。治热病伤津,口干烦渴,病后虚热,阴伤目暗。
山楂:酸、甘,微温。归脾、胃、肝经。功能与主治:消食健胃,行气散瘀,化浊降脂。用于肉食积滞,胃脘胀满,泻痢腹痛,瘀血经闭,产后瘀阻,心腹刺痛,胸痹心痛,疝气疼痛,高脂血症。焦山楂消食导滞作用增强。用于肉食积滞,泻痢不爽。
沙棘:酸、涩,温。功能与主治:止咳祛痰,消食化滞,活血散瘀。用于咳嗽痰多,消化不良,食积腹痛,瘀血经闭,跌扑瘀肿。
北沙参:甘、微苦,微寒。归肺、胃经。养阴清肺,益胃生津。用于肺热燥咳,劳嗽痰血,胃阴不足,热病津伤,咽干口渴。
鳖甲:咸,微寒。归肝、肾经。滋阴潜阳,退热除蒸,软坚散结。用于阴虚发热,骨蒸劳热,阴虚阳亢,头晕目眩,虚风内动。
牡蛎:咸,微寒。归肝、胆、肾经。功能与主治:重镇安神,潜阳补阴,软坚散结。用于惊悸失眠,眩晕耳呜,瘰疬痰核,癥瘕痞块。
玉竹:甘,微寒。归肺、胃经。功能与主治:养阴润燥,生津止渴。用于肺胃阴伤,燥热咳嗽,咽干口渴,内热消渴。
天花粉:甘、微苦,微寒。归肺、胃经。功能与主治:清热泻火,生津止渴,消肿排脓。用于热病烦渴,肺热燥咳,内热消渴,疮疡肿毒。
麦冬:甘、微苦,微寒。归心、肺、胃经。功能与主治:养阴生津,润肺清心。用于肺燥干咳,阴虚痨嗽,喉痹咽痛,津伤口渴,内热消渴,心烦失眠,肠燥便秘。
百合:甘,寒。归心、肺经。功能与主治:养阴润肺,清心安神。用于阴虚燥咳,劳嗽咳血,虚烦惊悸,失眠多梦,精神恍惚。
莲子:甘、涩,平。归脾、肾、心经。功能与主治:补脾止泻,止带,益肾涩精,养心安神。用于脾虚泄泻,带下,遗精,心悸失眠。
酸枣仁:甘、酸,平。归肝、胆、心经。功能与主治:养心补肝,宁心安神,敛汗,生津。用于虚烦不眠,惊悸多梦,体虚多汗,津伤口渴。
当归:甘、辛,温。归肝、心、脾经。功能与主治:补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,风湿痹痛,跌扑损伤,痈疽疮疡,肠燥便秘。
川芎:辛,温。归肝、胆、心包经。活血行气,祛风止痛。用于胸痹心痛,胸胁刺痛,跌扑肿痛,月经不调,经闭痛经,癥瘕腹痛,头痛,风湿痹痛。
延胡索:辛、苦,温。归肝、脾经。功能主治:活血,利气,止痛。用于胸胁、脘腹疼痛,经闭痛经,产后瘀阻,跌扑肿痛。
鸡血藤:味苦、微甘,性温,归肝经。具有行血补血、舒筋活络之功。现代研究表明,鸡血藤有改善造血系统、扩张血管、增加组织血流量、调节免疫、抗血栓、抗肿瘤的作用。
桑叶:甘、苦,寒。归肺、肝经。功能与主治:疏散风热,清肺润燥,清肝明目。用于风热感冒,肺热燥咳,头晕头痛,目赤昏花。
生地黄:清热凉血,养阴生津。用于热入营血,温毒发斑,吐血衄血,热病伤阴,舌绛烦渴,津伤便秘,阴虚发热,骨蒸劳热,内热消渴。
甘草:甘,平。归心、肺、脾、胃经。功能与主治:补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
中医理论中,糖尿病大都以“消渴”论治,肺主气为水之上源,肺燥热淫则伤气,津液不布则口渴多饮,饮水直下,虽尿量增多而渴不解,是为上消。脾胃主中焦,胃为水谷之海,主纳谷而降浊;脾为后天之本,主升清而运化精微。胃燥则胃火炽盛,消谷善饥口渴多饮。胃强则脾弱,脾弱则清浊逆乱,水谷精微反成湿浊下流,是为中消。肾为先天之本,胃之关门,主藏精而分清泌浊。久病穷肾,关门失司则固摄无权,水谷精微直趋下泄,是为下消。本发明以上述原料药组方,补脾益气健胃、补肾阳、舒肝理气、润肺安神、行气活血、养阴生津、清热润燥,从而从整体上补养精、气、神,调理五脏,并消除糖尿病的阴虚、消渴和燥热的症状。同时从现在医学来说,人参、黄芪、黄精、山药、白术、桑叶、生地黄、白芍、枸杞子、桑叶、天花粉、麦冬、玉竹等均具有降糖作用。因此,该组方治疗糖尿病的效果明显。
本发明的有益效果是:本发明以纯中药组方,可以有效治疗糖尿病。经临床验证,其治疗有效率为100%。采用本发明的药物治疗糖尿病治疗2-5个疗程后,不仅可以使血糖降到正常值,还可以在不用药的情况下维持血糖正常水平0.5-3年。
以下结合临床观察及典型病例来进一步说明其有益效果。
一、临床观察
1、临床资料:选择2013医院就诊和住院治疗的2型糖尿病的患者共253例进行临床观察,其中男145例,女108例;年龄48-75岁,病程0.5~15年。
2、诊断标准:2010年ADA糖尿病诊断标准
(1)糖化血红蛋白HbA1c≥6.5%;
(2)空腹血糖FPG≥7.0mmol/l,空腹定义为至少8小时内无热量摄入;
(3)口服糖耐量试验时2小时血糖≥11.1mmol/l;
(4)在伴有典型的高血糖或高血糖危象症状的患者,随机血糖≥11.1mmol/l;
在无明确高血糖时,应通过重复检测来证实标准(1)~(3)。
3、治疗方法:采用本发明实施例1的药物,水煎煮,每日1剂,分两次早晚服用。1个月为1个疗程。一般服用2-5个疗程。
4、疗效评定标准:
显效:空腹及餐后2小时血糖下降至正常范围,或空腹及餐后2小时血糖下降超过治疗前的40%,糖化血红蛋白下降至正常6.5%以下,或下降超过治疗前的30%;
有效:空腹及餐后2小时血糖下降超过治疗前的20%,但未达到显效标准,糖化血红蛋白下降超过治疗前的10%,但未达到显效标准;
无效:空腹及餐后2小时血糖无或略有下降,但未达到有效标准;糖化血红蛋白无或略有下降,但未达到有效标准。
5、治疗结果:经过2-5个疗程的治疗,253例患者中,显效228例,有效25例,无效0例,总有效率为100%。
二、典型病例
病例1:刘某,男,68岁。患者患糖尿病9年,5年前开始接受胰岛素治疗。患者2年前因腰膝酸软、多饮、多尿、多食及体重减轻。入院查体,尿糖+++;糖化血红蛋白(HbA1c):9.2%;空腹血糖(FBG):9.1mmol/L,餐后2h血糖(PBG):13.5mmol/L。经服用本发明实施例1的药物三个月后,糖化血红蛋白(HbA1c):6.8%;空腹血糖(FBG):7.2mmol/L,餐后2h血糖(PBG):11.8mmol/L,且三多一少及乏力症状明显减轻。继续服用1个月后,糖化血红蛋白(HbA1c):6.3%;空腹血糖(FBG):6.6mmol/L,餐后2h血糖(PBG):10.5mmol/L,且三多一少及乏力症状消失,尿糖为阴性。继续巩固治疗1个月,随访1年未复发。
病例2:孙某,女,51岁。患者近2年出现乏力、消瘦、多饮,自觉心烦等症状。实验室及辅助检查空腹血糖(FPG)9.4mmol/L,餐后2小时血糖13.3mmol/L(PBG),糖化血红蛋白指数(HbA1c)为9.5%。经过初步诊断为:糖尿病。经服用本发明实施例1的药物三个月后,糖化血红蛋白(HbA1c):6.4%;空腹血糖(FBG):6.7mmol/L,餐后2h血糖(PBG):11.0mmol/L,且三多一少、乏力、心烦症状消失。继续巩固治疗1个月,随访半年未复发。
病例3:王某,男,66岁。因“多饮、多尿、多食、乏力3年,加重1个月”于2013年1月入院。患者于8年前被诊断为“2型糖尿病”,口服多种降糖药物维持治疗,于1年前出现多饮、多尿、多食、乏力症状加重入院。入院查体:尿糖+++;空腹血糖(FPG)9.8mmol/L,餐后2小时血糖(PBG)14.3mmol/L,糖化血红蛋白指数(HbA1c)为9.8%。经服用本发明实施例1的药物4个月后,糖化血红蛋白:6.2%;空腹血糖(FBG):6.5mmol/L,餐后2h血糖(PBG):10.0mmol/L,且多饮、多尿、多食、乏力症状消失,尿糖为阴性。继续巩固治疗1个月,随访半年未复发。
具体实施方式
实施例1
配比(单位:克):人参20、黄芪30、何首乌25、黄精20、山药12、陈皮15、白术10、肉苁蓉20、女贞子15、紫河车8、枸杞子8、柴胡15、佛手10、香橼10、白芍8、石斛5、山楂12、沙棘10、北沙参8、鳖甲15、牡蛎8、玉竹8、天花粉8、麦冬8、百合8、莲子10、酸枣仁12、当归15、川芎10、延胡索8、鸡血藤5、桑叶5、生地黄10和甘草5。
配制及服用方法:水煎煮,每日1剂,分两次早晚服用。1个月为1个疗程。一般服用2-5个疗程。
实施例2
配比(单位:克):人参18、黄芪25、何首乌22、黄精18、山药10、陈皮12、白术8、肉苁蓉18、女贞子12、紫河车5、枸杞子5、柴胡12、佛手8、香橼8、白芍5、石斛3、山楂10、沙棘8、北沙参5、鳖甲12、牡蛎5、玉竹5、天花粉5、麦冬5、百合5、莲子8、酸枣仁10、当归12、川芎8、延胡索5、鸡血藤3、桑叶3、生地黄8和甘草3。
配制及服用方法:同实施例1。
实施例3
配比(单位:克):人参22、黄芪35、何首乌28、黄精22、山药15、陈皮18、白术12、肉苁蓉22、女贞子18、紫河车10、枸杞子10、柴胡18、佛手12、香橼12、白芍10、石斛8、山楂15、沙棘12、北沙参10、鳖甲18、牡蛎10、玉竹10、天花粉10、麦冬10、百合10、莲子12、酸枣仁15、当归18、川芎12、延胡索10、鸡血藤8、桑叶8、生地黄12和甘草8。
配制及服用方法:同实施例1。
实施例4
配比(单位:克):人参18、黄芪30、何首乌22、黄精22、山药15、陈皮12、白术10、肉苁蓉20、女贞子15、紫河车10、枸杞子10、柴胡12、佛手10、香橼10、白芍8、石斛5、山楂15、沙棘10、北沙参8、鳖甲12、牡蛎8、玉竹8、天花粉8、麦冬8、百合8、莲子10、酸枣仁15、当归15、川芎10、延胡索8、鸡血藤5、桑叶5、生地黄8和甘草3。
配制及服用方法:同实施例1。
Claims (2)
1.一种治疗糖尿病的药物,其特征是,由下述重量份的原料药制成:人参18-22、黄芪25-35、何首乌22-28、黄精18-22、山药10-15、陈皮12-18、白术8-12、肉苁蓉18-22、女贞子12-18、紫河车5-10、枸杞子5-10、柴胡12-18、佛手8-12、香橼8-12、白芍5-10、石斛3-8、山楂10-15、沙棘8-12、北沙参5-10、鳖甲12-18、牡蛎5-10、玉竹5-10、天花粉5-10、麦冬5-10、百合5-10、莲子8-12、酸枣仁10-15、当归12-18、川芎8-12、延胡索5-10、鸡血藤3-8、桑叶3-8、生地黄8-12和甘草3-8。
2.如权利要求1所述的一种治疗糖尿病的药物,其特征是,由下述重量份的原料药制成:人参20、黄芪30、何首乌25、黄精20、山药12、陈皮15、白术10、肉苁蓉20、女贞子15、紫河车8、枸杞子8、柴胡15、佛手10、香橼10、白芍8、石斛5、山楂12、沙棘10、北沙参8、鳖甲15、牡蛎8、玉竹8、天花粉8、麦冬8、百合8、莲子10、酸枣仁12、当归15、川芎10、延胡索8、鸡血藤5、桑叶5、生地黄10和甘草5。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510690480.3A CN105250723B (zh) | 2015-10-21 | 2015-10-21 | 一种治疗糖尿病的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510690480.3A CN105250723B (zh) | 2015-10-21 | 2015-10-21 | 一种治疗糖尿病的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105250723A true CN105250723A (zh) | 2016-01-20 |
CN105250723B CN105250723B (zh) | 2018-08-17 |
Family
ID=55090851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510690480.3A Expired - Fee Related CN105250723B (zh) | 2015-10-21 | 2015-10-21 | 一种治疗糖尿病的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105250723B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105596735A (zh) * | 2016-03-23 | 2016-05-25 | 陈佳宽 | 一种治疗糖尿病的药物组合物 |
CN106491990A (zh) * | 2016-12-05 | 2017-03-15 | 童守信 | 一种治疗2型糖尿病的中药组合物 |
CN107582859A (zh) * | 2017-10-25 | 2018-01-16 | 陆惠红 | 一种治疗糖尿病的中药 |
CN107789461A (zh) * | 2017-11-16 | 2018-03-13 | 李增龙 | 一种治疗女性ⅱ型糖尿病的药物 |
CN109350717A (zh) * | 2018-11-05 | 2019-02-19 | 穆春成 | 一种治疗消渴症的中药组合物 |
CN110140741A (zh) * | 2018-02-12 | 2019-08-20 | 河南科技学院 | 一种预防糖尿病的保健蛋糕 |
CN110464759A (zh) * | 2019-09-06 | 2019-11-19 | 江苏大学附属医院 | 一种防治糖尿病的组合物及其制备方法 |
CN110624061A (zh) * | 2019-10-28 | 2019-12-31 | 王守军 | 治疗糖尿病的中药及制备方法 |
CN113577192A (zh) * | 2021-04-29 | 2021-11-02 | 黄湘黔 | 一种治疗糖尿病药物及其制备、使用方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1326771A (zh) * | 2001-06-08 | 2001-12-19 | 王显勇 | 一种治疗糖尿病用药物 |
CN104666805A (zh) * | 2013-11-29 | 2015-06-03 | 烟台巨先药业有限公司 | 一种治疗糖尿病的中成药颗粒 |
-
2015
- 2015-10-21 CN CN201510690480.3A patent/CN105250723B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1326771A (zh) * | 2001-06-08 | 2001-12-19 | 王显勇 | 一种治疗糖尿病用药物 |
CN104666805A (zh) * | 2013-11-29 | 2015-06-03 | 烟台巨先药业有限公司 | 一种治疗糖尿病的中成药颗粒 |
Non-Patent Citations (2)
Title |
---|
卢晓琳等: "滋阴宁心法治疗2型糖尿病合并抑郁36例", 《辽宁中医杂志》 * |
李阳: "丹鸡逍遥散治疗血虚肝郁之糖尿病机制探讨", 《光明中医》 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105596735A (zh) * | 2016-03-23 | 2016-05-25 | 陈佳宽 | 一种治疗糖尿病的药物组合物 |
CN106491990A (zh) * | 2016-12-05 | 2017-03-15 | 童守信 | 一种治疗2型糖尿病的中药组合物 |
CN106491990B (zh) * | 2016-12-05 | 2019-09-03 | 童守信 | 一种治疗2型糖尿病的中药组合物 |
CN107582859A (zh) * | 2017-10-25 | 2018-01-16 | 陆惠红 | 一种治疗糖尿病的中药 |
CN107789461A (zh) * | 2017-11-16 | 2018-03-13 | 李增龙 | 一种治疗女性ⅱ型糖尿病的药物 |
CN110140741A (zh) * | 2018-02-12 | 2019-08-20 | 河南科技学院 | 一种预防糖尿病的保健蛋糕 |
CN109350717A (zh) * | 2018-11-05 | 2019-02-19 | 穆春成 | 一种治疗消渴症的中药组合物 |
CN110464759A (zh) * | 2019-09-06 | 2019-11-19 | 江苏大学附属医院 | 一种防治糖尿病的组合物及其制备方法 |
CN110624061A (zh) * | 2019-10-28 | 2019-12-31 | 王守军 | 治疗糖尿病的中药及制备方法 |
CN113577192A (zh) * | 2021-04-29 | 2021-11-02 | 黄湘黔 | 一种治疗糖尿病药物及其制备、使用方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105250723B (zh) | 2018-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105250723B (zh) | 一种治疗糖尿病的药物 | |
CN103251867A (zh) | 一种治疗糖尿病的中药复方药物及其制备方法 | |
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN104042909A (zh) | 一种治疗糖尿病的药物 | |
CN102631512B (zh) | 一种治疗慢性结肠炎的中药组合物 | |
CN102526498A (zh) | 治疗鼻咽癌放疗后毒副作用的中药、制备方法及给药方式 | |
CN104857288B (zh) | 治疗白发的中药制剂及其制备方法 | |
CN104784538B (zh) | 一种治疗糖尿病的中药制剂及制备方法 | |
CN106994141B (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
CN102430013A (zh) | 治疗白癜风的中药 | |
CN104800771A (zh) | 一种用于儿童夜惊症的中药制剂及其制备方法 | |
CN102423481A (zh) | 治疗糖尿病的药物及制备方法 | |
CN102935214B (zh) | 一种治疗尿毒症的中药组合物 | |
CN101085279A (zh) | 一种治疗尿毒症的中药 | |
CN105213758A (zh) | 一种治疗慢性肺炎的中药组合物及其制备方法 | |
CN109498745A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN108904746A (zh) | 一种治疗溃疡性结肠炎的中药组合物及其制备方法和应用 | |
CN103263628A (zh) | 一种治疗糖尿病的中药 | |
CN108853340A (zh) | 一种滋养肝肾的中药及其制备方法 | |
CN107737292B (zh) | 治疗老年人夜尿症的中药制剂及其制备方法 | |
CN107583029A (zh) | 用于治疗慢性肠炎的中药组合物及其制备方法 | |
CN105727137A (zh) | 一种治疗糖尿病的中药 | |
CN105878732A (zh) | 一种治疗糖尿病的中药及其制备方法 | |
CN113876924A (zh) | 一种治疗抑郁症的中药配方 | |
CN106267086A (zh) | 一种治疗原发性青光眼的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180817 Termination date: 20191021 |
|
CF01 | Termination of patent right due to non-payment of annual fee |